A. Gerken

1.2k total citations
13 papers, 634 citations indexed

About

A. Gerken is a scholar working on Behavioral Neuroscience, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, A. Gerken has authored 13 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Behavioral Neuroscience, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pharmacology. Recurrent topics in A. Gerken's work include Stress Responses and Cortisol (7 papers), Adrenal Hormones and Disorders (5 papers) and Treatment of Major Depression (5 papers). A. Gerken is often cited by papers focused on Stress Responses and Cortisol (7 papers), Adrenal Hormones and Disorders (5 papers) and Treatment of Major Depression (5 papers). A. Gerken collaborates with scholars based in Germany. A. Gerken's co-authors include G. K. Stalla, Otto Müller, Axel Steiger, P. Vecsei, D. Haack, F Holsboer, Otto Benkert, O. A. Müller, Günter K. Stalla and U. von Bardeleben and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Psychoneuroendocrinology.

In The Last Decade

A. Gerken

13 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gerken Germany 10 459 283 212 133 109 13 634
F Brambilla Italy 16 296 0.6× 242 0.9× 134 0.6× 71 0.5× 63 0.6× 42 732
Johan Beck-Friis Sweden 13 245 0.5× 196 0.7× 145 0.7× 63 0.5× 76 0.7× 20 903
Irene Kürten Germany 15 281 0.6× 105 0.4× 234 1.1× 46 0.3× 55 0.5× 25 727
Jürgen‐Christian Krieg Germany 7 234 0.5× 122 0.4× 78 0.4× 91 0.7× 71 0.7× 10 556
Marie‐Claude Mokrani France 18 293 0.6× 225 0.8× 189 0.9× 79 0.6× 81 0.7× 36 680
Alan F. Schatzberg United States 6 200 0.4× 139 0.5× 79 0.4× 46 0.3× 83 0.8× 6 442
Frieda S. Halpern United States 20 307 0.7× 203 0.7× 291 1.4× 70 0.5× 113 1.0× 36 1.0k
Richard Hauger United States 10 353 0.8× 111 0.4× 105 0.5× 170 1.3× 43 0.4× 15 622
Jean‐Michel Le Mellédo Canada 16 306 0.7× 181 0.6× 89 0.4× 182 1.4× 62 0.6× 29 877
Janet Tarika United States 8 226 0.5× 185 0.7× 76 0.4× 46 0.3× 201 1.8× 10 554

Countries citing papers authored by A. Gerken

Since Specialization
Citations

This map shows the geographic impact of A. Gerken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gerken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gerken more than expected).

Fields of papers citing papers by A. Gerken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gerken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gerken. The network helps show where A. Gerken may publish in the future.

Co-authorship network of co-authors of A. Gerken

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gerken. A scholar is included among the top collaborators of A. Gerken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gerken. A. Gerken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gerken, A., et al.. (1991). Extrapyramidal Symptoms and their Relationship to Clinical Efficacy under Perphenazine Treatment*. Pharmacopsychiatry. 24(4). 132–137. 9 indexed citations
2.
Bardeleben, U. von, et al.. (1989). Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.. PubMed. 4 Suppl 1. 31–5. 4 indexed citations
3.
Steiger, Axel, et al.. (1989). Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.. PubMed. 4 Suppl 1. 1–5. 42 indexed citations
5.
Gerken, A., et al.. (1987). Blunted aldosterone and ACTH release after human CRH administration in depressed patients. American Journal of Psychiatry. 144(2). 229–231. 69 indexed citations
6.
Gerken, A., U. von Bardeleben, W. Grimm, et al.. (1986). Human corticotropin-releasing hormone in depression—correlation with thyrotropin secretion following thyrotropin-releasing hormone. Biological Psychiatry. 21(7). 601–611. 103 indexed citations
7.
Maier, Wolfgang, et al.. (1985). Dimensionen der Hamilton-Depressionsskala (HAMD): Faktorenanalytische Untersuchungen. 234(6). 417–422. 2 indexed citations
8.
Maier, Wolfgang, Michael Philipp, & A. Gerken. (1985). Dimensionen der Hamilton-Depressionsskala (HAMD). European Archives of Psychiatry and Clinical Neuroscience. 234(6). 417–422. 40 indexed citations
9.
Gerken, A., et al.. (1985). ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biological Psychiatry. 20(3). 276–286. 86 indexed citations
10.
11.
Holsboer, F, D. Haack, A. Gerken, & P. Vecsei. (1984). Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.. PubMed. 19(3). 281–91. 79 indexed citations
12.
Gerken, A., et al.. (1984). Mean 14.00–17.00 h plasma cortisol concentration and its relationship to the 1 mg‐dexamethasone suppression response in depressives and controls. Acta Psychiatrica Scandinavica. 69(5). 383–390. 36 indexed citations
13.
Müller, Oliver J., Hans Wilhelm Doerr, W.G. Sippell, et al.. (1984). ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinology. 9(2). 147–160. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026